Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD-Reference-Cited by-同舟云学术

Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD

Published:2016-04-19 Issue:6 Volume:11 Page:982-991
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Provenzano Robert,Besarab Anatole,Sun Chao H.,Diamond Susan A.,Durham John H.,Cangiano Jose L.,Aiello Joseph R.,Novak James E.,Lee Tyson,Leong Robert,Roberts Brian K.,Saikali Khalil G.,Hemmerich Stefan,Szczech Lynda A.,Yu Kin-Hung Peony,Neff Thomas B.

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference38 articles.

1. Trends in anemia treatment with erythropoietin usage and patient outcomes

2. Prevalence of Chronic Kidney Disease in the United States

3. Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin

4. A rationale for an individualized haemoglobin target.;Muirhead;Nephrol Dial Transplant,2002

5. Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applying cell painting in non-tumorigenic breast cells to understand impacts of common chemical exposures;Toxicology in Vitro;2024-12

2. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors as a New Treatment Option for Anemia in Chronic Kidney Disease;Biomedicines;2024-08-18

3. Efficacy and Safety of Roxadustat Compared to Erythropoiesis-Stimulating Agents in the Treatment of Renal Anaemia in Haemodialysis Patients: A Meta-Analysis;International Journal of Pharmacology;2024-08-01

4. The Efficacy and Safety of Roxadustat for the Treatment of Posttransplantation Anemia: A Randomized Study;Kidney International Reports;2024-06

5. Mild Thermotherapy‐Assisted GelMA/HA/MPDA@Roxadustat 3D‐Printed Scaffolds with Combined Angiogenesis‐Osteogenesis Functions for Bone Regeneration;Advanced Healthcare Materials;2024-05-11